Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.57
USD |
NASDAQ |
Jun 03, 16:00
Fusion Pharmaceuticals Enterprise Value: 1.672B for June 4, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 317.56B |
| Landos Biopharma Inc (DELISTED) | 42.67M |
| Grace Therapeutics, Inc. | 37.92M |
| Aurinia Pharmaceuticals, Inc. | 1.703B |
| Edesa Biotech, Inc. | 8.872M |
Enterprise Value Related Metrics
| Earnings Yield | -6.59% |
| Normalized Earnings Yield | -7.564 |